2AC2 Dietzschold, Bernhard - Thomas Jefferson University - Thomas Jefferson University
bxd108

Bernhard Dietzschold, DVM

Contact Dr. Dietzschold


Philadelphia, PA 19107

(215) 503-4692

Most Recent Peer-reviewed Publications

  1. Limited brain metabolism changes differentiate between the progression and clearance of rabies virus
  2. Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies
  3. Postexposure treatment with the live-attenuated rabies virus (rv) Vaccine trigas triggers the clearance of wild-type rv from the central nervous system (cns) Through the rapid induction of genes relevant to adaptive immunity in cns tissues
  4. The Role of Toll-Like Receptors in the Induction of Immune Responses During Rabies Virus Infection
  5. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine
  6. Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans
  7. Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife
  8. Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus
  9. Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers
  10. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
  11. Concepts in the pathogenesis of rabies
  12. Role of virus-induced neuropeptides in the brain in the pathogenesis of rabies
  13. The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread
  14. Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway
  15. Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines
  16. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus
  17. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease
  18. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice
  19. Rabies virus glycoprotein as a carrier for anthrax protective antigen
  20. Vaccination of small Asian mongoose (Herpestes javanicus) against rabies
0